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Epidemiological data have suggested an increased cancer rates in diabetic patients, for which the underlying 
mechanism is poorly understood. We studied whether high level of glucose (HG) treatment that mimic the 
hyperglycemic condition in diabetes mellitus is mutagenic. Mutagenesis studies were carried out at both 
hypoxanthine phosphoribosyltransferase (hprt) and thymidine kinase (tk) loci. Role of p53 in HG-induced 
mutagenesis was also investigated by using human lymphoblastoid cell lines derived from same donor but 
differs in p53 statuses; TK6 has wild-type p53, NH32 has null p53, and WTK1 has mutant p53 (ile237). In 
addition, we studied the influence of antioxidant treatment on HG-induced mutagenesis. Mutation fractions at 
both loci increased significantly in all three lines at 21 and 28 days after HG treatments. At tk locus, the increase of 
a class of mutants with normal growth rate is mainly responsible for the overall increased mutant fraction. 
Compared to TK6 cells, both NH32 and WTK1 cells showed an early onset of mutagenesis. Treatment of cells 
with antioxidant N-acetyl-L-cysteine partially reduced HG induced mutagenesis. This study is the first to 
indicate that HG is able to induce gene mutation w h i c h  m a y  b e  o n e  o f  t h e  important mechanisms of 
diabetes-associated carcinogenesis. 
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1.  Introduction 
The prevalence of diabetes mellitus is increasing 
dramatically worldwide and various diabetic 
complications threat severely the life of diabetic 
patients. Epidemiological data have suggested an 
increased cancer rates in diabetic patients, including 
primary liver cancer [1, 2], pancreatic cancer [1, 3], 
colorectal [4, 5], endometrial [6, 7], breast [8, 9], and 
renal cancer [10]. However, the mechanism of 
diabetes-associated carcinogenesis is unclear. 
Hyperglycemia in diabetic subjects is widely 
recognized as the major cause for diabetes 
complications, mainly via overgeneration of reactive 
oxygen species (ROS) [11]. Fact that diabetes or 
hyperglycemia causes DNA damage by oxidation to 
bases and the sugar-phosphates has been 
demonstrated recently [12, 13]. These DNA damages is 
likely responsible for the increased cancer in diabetes 
mellitus. Gene mutation is one of the important 
mechanisms of carcinogenesis [14]; however whether 
diabetes or hyperglycemia induces gene mutations has 
not been addressed yet. We hypothesize that 
hyperglycemia may induce gene mutation via 
ROS-induced DNA damage, and such gene mutations 
may be one of the important mechanisms of 
diabetes-associated carcinogenesis. 
In this study, therefore, we have investigated the 
mutagenic effects in human lymphoblastoid cells 
treated with high level of glucose (HG) that mimic the 
hyperglycemia in diabetic subjects. We carried out 
mutagenesis studies at both X-linked hypoxanthine 
phosphoribosyltransferase (hprt) and autosomal 
thymidine kinase (tk) loci. Because p53 has been 
implicated in DNA damage response, mutagenesis 
and tumorigenesis [15], the status of p53 may also play 
a role in hyperglycemia mediated mutagenesis. We 
thus selected TK6, NH32, and WTK1 cells in this study 
since all these three lines were derived from same 
donor but differed in p53 status; TK6 has wild-type 
p53, NH32 has null p53, and WTK1 has mutant p53 
(ile237) that is one of the most common mutations of 
p53 gene in human cancers and has been found to 
promote mutagenesis [16]. In addition, we studied the 
influence of antioxidant treatment on HG-induced 
mutagenesis.   
2.  Materials and Methods   
Cell culture  
Human lymphoblast cell lines TK6, NH32, and 
WTK1 are derived from Epstein-Barr virus 
transformed WI-L2 line. TK6 contains a wild-type p53 Int. J. Biol. Sci. 2007, 3 
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gene, NH32 contains null p53 mutation, and WTK1 
harbors hemizygous or homozygous p53 mutation 
(p53ile237) and contains no wild-type p53, thus, 
mutation assay data obtained from these cell lines can 
provide useful information about the role of p53 in 
mutagenesis [17]. All lines were derived from a male 
and there is only one copy of X-linked hprt gene, which 
makes both lines applicable to carry out mutagenesis 
study at hprt locus. In addition, all lines are 
heterozygous for the autosomal tk gene on 
chromosome 17q21-23, which makes them widely 
used in mutagenesis studies at autosomal locus [18]. 
All cell lines were maintained as exponentially 
growing cultures in RPMI 1640 medium supplemented 
with 10% heat inactivated horse serum, 100u/ml 
penicillin, and 100μg/ml streptomycin. Cultures were 
incubated at 37oC in 5% CO2 and 100% humidity and 
maintained at densities of 1-10 × 105 cells/ml. Cultures 
were treated with either 22 mmol/l D-glucose (Sigma) 
to mimic hyperglycemia condition in patients, or 5.5 
mmol/l glucose as control. To exclude a hyperosmolar 
effect, we added extra 16.5 mmol/l mannitol (Sigma) 
in control cultures. N-acetyl-L-cysteine (L-NAC) was 
purchased from Sigma and added to culture at final 
concentration of 10mM/l. NAC treatments were 
carried out daily for 2h. After culturing with glucose 
for varying time periods, the cultures were washed 
with normal medium and the cells were subjected to 
mutation assay. 
Mutation assay 
We use both hprt and tk as marker genes to study 
mutagenesis. Both genes code for non-essential 
salvage pathway enzymes involved in nucleotide 
metabolism and are similar in that any mechanism 
which eliminates gene function will produce a mutant, 
thus, the mutants will be selected easily by colony 
forming assay when cells are cultured in selective 
agents. We used our standard protocol to carry out 
mutagenesis study [18]. Briefly, prior to be used in 
mutation assay, cells were grown in CHAT medium 
(complete RPMI 1640 medium with 10-5 M 
deoxycytidine, 2×10-4M hypoxanthine, 2×10-7 M 
aminopterin, and 1.75×10-5 M thymidine) for 2 days to 
reduce the background hprt- and tk-/- mutants. The cells 
were then allowed to recover for 1 day in THC (10-5 M 
deoxycytidine, 2×10-4 M hypoxanthine, and 1.75×10-5 M 
thymidine). At various days after glucose treatment, 
cultures were grown in normal medium for either 3 or 
6 days to allow the expression of mutant phenotype; 3 
days for tk-/- and 6 days for hprt- mutants. After 
expression, cells were seeded into 96-well plates at 
various densities in the presence of selective agents; 
0.5μg/ml 6-thioguinine to select hprt- mutants or 
2μg/ml trifluorothymidine (TFT) to select tk-/- mutants. 
For  hprt- mutant selection, cells were seeded at a 
density of 20000 cells/well in 0.2ml medium/well. For 
tk-/- mutant selection, TK6 and NH32 cells were seeded 
at a density of 20000 cells/well in 0.2ml medium. 
WTK1 cells were seeded at a density of 20000 
cells/well in 0.2ml medium. Cells from each sample 
were also seeded at 1 cell/well in the absence of 
selective agents to determine plating efficiency (PE). 
The colonies cultured with 6-thioguinine were 
determined to be hprt mutants and scored at 11 days 
after seeding. The colonies cultured with TFT scored at 
11 days are classified to be tk normal growth mutants 
(tk-NG). For plates for selecting tk-/- mutants, 0.02ml of 
20μg/ml TFT was refed to restore the concentration of 
TFT since TFT is unstable in medium and extended 
incubation causes TFT to degrade, resulting in an 
outgrowth of wild type colonies which escape initial 
selection. After refeeding, the plates were incubated 
for another 10 days, and the newly formed colonies 
were classified to be tk slow growth (tk-SG) mutants 
[19]. The sum of tk-NG and tk-SG were determined to 
be overall mutants. 
Statistical Analysis 
Statistical analyses were done on the means of the 
data obtained from three independent experiments. 
All results were presented as means ± SD. Significance 
was assessed by using student’s t test at p < 0.05. 
3.  Results and Discussion 
Previous studies have demonstrated that DNA 
damage-caused mutations at autosomal tk locus 
include tk-NG mutants that arise 11 days after plating 
with similar growth rate to their parental cells, and 
tk-SG mutants that arise 21 days after plating with 
slower growth rate than their parental cells [19]. At 
hprt locus, all mutants arise at 11 days after plating 
with similar growth rate to their parental cells. It is 
well-known that the different molecular natures of 
DNA damage led to the formation of various mutants; 
large genetic alterations that affect cell-growth-related 
genes around tk locus are responsible for the slow 
growth phenotype in tk-SG mutants, whereas small 
genetic alterations that does not affect 
cell-growth-related genes around tk locus and hprt 
locus are responsible for the phenotype of the normal 
growth in hprt and tk-NG mutants [19]. We, therefore, 
measured the MFs for both hprt and tk loci at different 
days after HG-treatment in three cell lines. As seen in 
Fig. 1 and Fig. 2a, all cell lines showed an increase in 
the MFs at hprt locus and at tk locus at 21 and 28 days 
after HG treatment, compared with control (p<0.05). A 
trend of increase without statistical significance in 
NH32 cells (p>0.05) and significant increase in WTK 
cells (p<0.05) were also found at 14 days after 
HG-treatment. Induction of the two locus mutations 
(autosomal tk and X-linked hprt) in the three cell lines 
exposed to HG for 21 days strongly indicates the 
mutagenic effect of HG. 
Gene mutations can be formed at different scales, 
either small deletions of the entire genes of hprt or tk or 
larger deletions that span one or more genes. The latter 
will not be detectable because the affected cells would 
not survive. Therefore, large genetic alterations along 
X-linked hprt locus are lethal and escape the mutagenic 
assay. However, because of the presence of the 
homologous chromosome and genes, large multilocus 
deletions of autochromosome genes such as tk locus 
remain detectable in mutagenic assay [19]. Therefore Int. J. Biol. Sci. 2007, 3 
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we further examined the effects of HG on mutations of 
tk-NG and tk-SG separately (Fig. 2b,c). It is shown that 
there was no increased tk-SG in TK6 and NH32 cells 
even at 28 days after HG treatment, while MFs of tk-SG 
was slightly increased without statistical significance 
at day 14 and 21 (p>0.05) and significantly increased at 
day 28 (p<0.05) after HG treatment (Fig. 2c), 
suggesting that increased tk-NG is mainly responsible 
for the overall increased MF at tk locus in TK6 and 
NH32 cells, while both tk-NG and tk-SG mutations 
occur in WTK1 cells in response to HG. 
 
Fig. 1. HG-induced mutagenesis at hprt locus.  At indicated days after HG treatment, TK6, NH32, and WTK1 cells were collected 
for mutagenesis study. * p<0.05 compared to control, # p<0.05 compared to HG-treatment. 
 
Apparently, the difference for the onset time in 
hprt and tk-NG mutation, and mutation types among 
three cells lines is related with p53. In contrast to p53 
wild type TK6 cells, both NH32 with a null p53 and 
WTK1 cells with a mutant p53 showed an early onset 
of HG-induced mutagenesis. In addition, WTK1 cells 
showed an increased MF for tk-SG at 28 days after HG 
treatment, which is different from TK6 and NH32 cells. 
p53 is a transcription factor that serves as a potent 
tumor suppressor. Inactivating mutations in the p53 
protein are found in over 50% of cancers, suggesting 
loss of p53 function provides a selective advantage to 
tumor cells that may contain gene mutation [20]. 
Mutation of p53 sensitizes cells to endogenous and 
environmental mutagens. For example, compared to 
TK6, WTK1 cells are approximately 10 folds more, and 
NH32 cells are approximately 1.5 folds high sensitivity 
to ionizing radiation-induced mutagenesis [17, 18]. 
Upon DNA damage, cells utilize multiple DNA repair 
pathways to mend damaged DNA including 
nucleotide excision repair, mismatch repair, base 
excision repair, homologous recombination, and 
non-homologous end joining pathways. p53 involves 
in all these DNA damage repair pathways by either 
direct association with or transcriptional modulation 
of the key players in the above repair pathways [20]. 
Impairment of the above pathways results in 
u n f a i t h f u l  r e p a i r  o f  D N A  d a m a g e  t h a t  m a y  l e a d  t o  
increased mutagenesis. These may explain why NH32 
and WTK1 cells display an early onset and high 
incidence of gene mutations (Fig. 1, Fig. 2b) since the 
lack or mutant of p53 function may impair DNA repair 
mechanisms. However, it should be mentioned that 
the DNA repair by homologous recombinational 
activity was found remarkably increased in WTK1 
cells due to the mutant p53 function, i.e.: about 7-folds 
higher than that in TK6 cells. The increased 
homologous recombinational DNA repair activity 
would improve the large scale DNA damage via loss 
of heterozygosity and be thus related with slow 
growth phenotype [16]. This suggests that in WTK1 
cells, the mutant p53 significantly increased abnormal 
homologous recombinational repair in response to 
HG, leading to an increased large-scale DNA damage, 
such as tk-SG. 
It has been noted that ROS-induced DNA damage 
is mainly small scale, such as base pair substitution, 
small scale insertion and deletions [21]. We have 
shown that cells produce ROS in response to HG 
treatment [22, 23]. In consistent with these studies, we 
demonstrated in the present study that there is 
predominant increase in tk-NG (Fig. 2b) that most 
likely contributes to the increase in tk-overall gene 
mutations (Fig. 2a), suggesting the possible role of 
HG-induced ROS in the induction of gene mutations. 
To further define the direct link of HG-induced ROS to 
gene mutations, we demonstrated that the addition of 
ROS scavenger NAC in the cultured cells exposed to 
HG partially, but significantly, prevented HG-induced 
hprt and tk-NG MFs (Fig. 1 and Fig. 2). 
The exact explanation of why NAC partially 
prevents HG-induced gene mutations is unclear based 
on the present study, however, it may be related to the 
fact that gene mutation is related both DNA damage 
and repair process, i.e.: either increase in DNA damage 
or decrease in DNA repair ability. Diabetic Int. J. Biol. Sci. 2007, 3 
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hyperglycemia or HG has been extensively 
documented to inactivate protein action such as 
antioxidants and enzymes by glycation or nitration [24, 
25]. NAC may be unable to prevent protein glycation, 
and thus unable to prevent the contribution of 
glycation-inactivated DNA repair enzymes to 
HG-induced DNA damage and consequently gene 
mutations. In addition, glyoxal as an intermediate of 
HG metabolism was found to induce DNA base 
damage via ROS-independent pathways [13]. 
Therefore, the present study shows only partial 
prevention of NAC against HG-induced gene 
mutations (Fig. 1 and Fig. 2). 
 
Fig. 2. HG-induced mutagenesis at tk locus. At indicated days after HG treatment, TK6, NH32, and WTK1 cells were collected for 
mutagenesis study. Panel a is for overall MF, panel b is for tk-NG MF, and panel c is for tk-SG MF. * p<0.05 compared to control, # 
p<0.05 compared to HG-treatment. Int. J. Biol. Sci. 2007, 3 
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4.  Conclusion 
In summary, we have shown that HG treatment 
leads to increased mutagenesis in human 
lymphoblastoid cells. ROS may play partial role in 
HG-induced mutagenesis, and null or mutant p53 
function makes cells more susceptible to HG-induced 
mutagenic effect. Thus, the present study provides the 
first and direct evidence for HG-induced gene 
mutations, which provides novel insight into 
understanding the mechanism of cancer risk in 
diabetes mellitus. 
Acknowledgements 
This study is supported in part by research grants 
from American Diabetes Association (02-07-JF-02; 
05-07-CD-02), Philip Morris USA, Inc. (020187), and a 
start-up fund for the Chinese-American Research 
Institute for Diabetic Complications from Wenzhou 
Medical College (to L.C.). 
Conflict of interest 
The authors have declared that no conflict of 
interest exists. 
References 
1.   Wideroff L., Gridley G., Mellemkjaer L., Chow W.H., Linet M., 
Keehn S., et al. Cancer incidence in a population-based cohort of 
patients hospitalized with diabetes mellitus in Denmark. J Natl 
Cancer Inst. 1997;89(18):1360-5. 
2.   La Vecchia C., Negri E., Decarli A., and Franceschi S. Diabetes 
mellitus and the risk of primary liver cancer. Int J Cancer. 
1997;73(2):204-7. 
3.  Chow W.H., Gridley G., Nyren O., Linet M.S., Ekbom A., 
Fraumeni J.F., et al. Risk of pancreatic cancer following diabetes 
mellitus: a nationwide cohort study in Sweden. J Natl Cancer 
Inst. 1995;87(12):930-1. 
4.   La Vecchia C., Negri E., Decarli A., and Franceschi S. Diabetes 
mellitus and colorectal cancer risk. Cancer Epidemiol 
Biomarkers Prev. 1997;6(12):1007-10. 
5.   Le Marchand L., Wilkens L.R., Kolonel L.N., Hankin J.H., and 
Lyu L.C. Associations of sedentary lifestyle, obesity, smoking, 
alcohol use, and diabetes with the risk of colorectal cancer. 
Cancer Res. 1997;57(21):4787-94. 
6.   Brinton L.A., Berman M.L., Mortel R., Twiggs L.B., Barrett R.J., 
Wilbanks G.D., et al. Reproductive, menstrual, and medical risk 
factors for endometrial cancer: results from a case-control study. 
Am J Obstet Gynecol. 1992;167(5):1317-25. 
7.   La Vecchia C., Negri E., Franceschi S., D'Avanzo B., and Boyle P. 
A case-control study of diabetes mellitus and cancer risk. Br J 
Cancer. 1994;70(5):950-3. 
8.  Sellers T.A., Sprafka J.M., Gapstur S.M., Rich S.S., Potter J.D., 
Ross J.A., et al. Does body fat distribution promote familial 
aggregation of adult onset diabetes mellitus and 
postmenopausal breast cancer? Epidemiology. 1994;5(1):102-8. 
9.   Weiderpass E., Gridley G., Persson I., Nyren O., Ekbom A., and 
Adami H.O. Risk of endometrial and breast cancer in patients 
with diabetes mellitus. Int J Cancer. 1997;71(3):360-3. 
10. Lindblad P., Chow W.H., Chan J., Bergstrom A., Wolk A., Gridley 
G., et al. The role of diabetes mellitus in the etiology of renal cell 
cancer. Diabetologia. 1999;42(1):107-12. 
11. Cai L., and Kang Y.J. Oxidative stress and diabetic 
cardiomyopathy: a brief review. Cardiovasc Toxicol. 
2001;1(3):181-93. 
12. Blasiak J., Arabski M., Krupa R., Wozniak K., Zadrozny M., 
Kasznicki J., et al. DNA damage and repair in type 2 diabetes 
mellitus. Mutat Res. 2004;554(1-2):297-304. 
13. Shimoi K., Okitsu A., Green M.H., Lowe J.E., Ohta T., Kaji K., et 
al. Oxidative DNA damage induced by high glucose and its 
suppression in human umbilical vein endothelial cells. Mutat 
Res. 2001;480:371-8. 
14. Toyokuni S. Novel aspects of oxidative stress-associated 
carcinogenesis. Antioxid Redox Signal. 2006;8(7-8):1373-7. 
15. Gatz S.A., and Wiesmuller L. p53 in recombination and repair. 
Cell Death Differ. 2006;13(6):1003-16. 
16. Xia F., Amundson S.A., Nickoloff J.A., and Liber H.L. Different 
capacities for recombination in closely related human 
lymphoblastoid cell lines with different mutational responses to 
X-irradiation. Mol Cell Biol. 1994;14(9):5850-7. 
17. Peng Y., Zhang Q., Nagasawa H., Okayasu R., Liber H.L., and 
Bedford J.S. Silencing expression of the catalytic subunit of 
DNA-dependent protein kinase by small interfering RNA 
sensitizes human cells for radiation-induced chromosome 
damage, cell killing, and mutation. Cancer Res. 
2002;62(22):6400-4. 
18. Zhang Y., Lim C.U. K., Williams E.S., Zhou J., Zhang Q., Fox 
M.H., et al. NBS1 Knockdown by Small Interfering RNA 
Increases Ionizing Radiation Mutagenesis and Telomere 
Association in Human Cells. Cancer Res. 2005;65(13):5544-53. 
19. Liber H.L., Yandell D.W., and Little J.B. A comparison of 
mutation induction at the tk and hprt loci in human 
lymphoblastoid cells; quantitative differences are due to an 
additional class of mutations at the autosomal tk locus. Mutat 
Res. 1989;216(1):9-17. 
20. Helton E.S., and Chen X. p53 modulation of the DNA damage 
response. J Cell Biochem. 2007;100(4):883-96. 
21. Diaz-Llera S., Podlutsky A., Osterholm A.M., Hou S.M., and 
Lambert B. Hydrogen peroxide induced mutations at the HPRT 
locus in primary human T-lymphocytes. Mutat Res. 
2000;469(1):51-61. 
22. Cai L., Li W., Wang G., Guo L., Jiang Y., and Kang Y.J. 
Hyperglycemia-induced apoptosis in mouse myocardium: 
mitochondrial cytochrome C-mediated caspase-3 activation 
pathway. Diabetes. 2002;51(6):1938-48. 
23. Cai L., Wang J., Li Y., Sun X., Wang L., Zhou Z., et al. Inhibition of 
superoxide generation and associated nitrosative damage is 
involved in metallothionein prevention of diabetic 
cardiomyopathy. Diabetes. 2005;54(6):1829-37. 
24. Zeng J., Dunlop R.A., Rodgers K.J., and Davies M.J. Evidence for 
inactivation of cysteine proteases by reactive carbonyls via 
glycation of active site thiols. Biochem J. 2006;398(2):197-206. 
25. Turko I.V., Marcondes S., and Murad F. Diabetes-associated 
nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid 
CoA-transferase. Am J Physiol Heart Circ Physiol. 
2001;281(6):H2289-94. 
 
 